10:44 AM EST - Tetra Bio-Pharma Inc. : Announced today that numerous pre-launch activities for REDUVO™ have been initiated. REDUVO™ is a cannabinoid-derived drug indicated in chemotherapy-induced nausea and vomiting. In December 2020, the Company submitted a New Drug Submission to Health Canada which is currently in its final stage of review by the regulator. Tetra Bio-Pharma Inc.
shares T.TBP are trading up $0.045 at $0.27.
